Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

about

Therapeutic benefits of nanoparticles in stroke Targeting Renin-Angiotensin System Against Alzheimer's Disease.

P2860

Q38515290-B2D48E49-5C82-4CA7-8488-F42E68480144 Q55007046-AD446D9E-1DB6-41DB-92F2-B94E18C7A956

P2860

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

Item

http://www.wikidata.org/entity/Q46792828

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

@en

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

@nl

type

Item

label

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

@en

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

@nl

prefLabel

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

@en

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

@nl

P1476

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

@en

P2093

Gohei So

http://www.w3.org/2001/XMLSchema#string

Izumi Nagata

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Suyama

http://www.w3.org/2001/XMLSchema#string

Kentaro Hayashi

http://www.w3.org/2001/XMLSchema#string

Kunihiko Tanaka

http://www.w3.org/2001/XMLSchema#string

Masami Niwa

http://www.w3.org/2001/XMLSchema#string

Shinsuke Nakagawa

http://www.w3.org/2001/XMLSchema#string

Takayuki Matsuo

http://www.w3.org/2001/XMLSchema#string

P2860

Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B.

Development of the blood-brain barrier.

Dynamics of CNS barriers: evolution, differentiation, and modulation.

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Inverse agonism and its therapeutic significance.

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis.

Commercially available angiotensin II At₂ receptor antibodies are nonspecific.

P2888

s10571-014-0152-8

P304

563-572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10571-014-0152-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mária A. Deli

Yoichi Morofuji

Takeshi Hiu

P577

2014-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270291937

http://www.w3.org/2001/XMLSchema#string

P698

25547389

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

about

P2860

P2860

Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921